Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07226336 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dietary Interventions to Reduce Ultra-Processed Food Intake

Study acronym: DISRUPT
StatusCompleted
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Completed without a posted recruiting period Show 8 more changesShow less
    • Enrollment target: estimated 60 to confirmed 59
    • Study sites: 0 to 1
    • Primary and study completion dates changed from estimate of Aug 2026 to Jul 31, 2026
    • Start date changed from estimate of Feb 2026 to Feb 10, 2026
    • Interventions: Cognitive Dissonance Strategies (ON/OFF) (Behavioral), Introductory Educational Workshop (Behavioral), Standard Dietary Change (ON/OFF)… to Cognitive Dissonance Strategies (ON/OFF) (Behavioral), Introductory Educational Workshop (Behavioral), Standard Dietary Change (ON/OFF)…
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 7 of 7 entries
    • Publications: details revised at 1 of 1 entry
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The DISRUPT clinical trial will test two different 2-month programs to help adults with overweight/obesity (N=60) reduce their intake of ultra-processed foods (UPFs). Participants will be randomly assigned to receive standard dietary change strategies, cognitive dissonance strategies that engage them in activism against the UPF industry, or both. All participants will attend an introductory educational workshop about UPFs. If they are assigned to receive one or more of these strategies, they will attend weekly group sessions with the relevant intervention content for 7 more weeks. Groups will be held virtually.
Trial Details
NCT Number NCT07226336
Lead Sponsor Oregon Research Institute
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Albert Einstein College of Medicine
Conditions
(from sponsor)		 Ultra-Processed Food Intake, Obesity & Overweight
Related terms Obesity, Overweight
Enrollment 59 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov